The specificity of the Ab1 anti-CD55 monoclonal antibody was confirmed by flow cytometry analysis of CD55-positive H460 cells (NSCLC derived from pleural effusions) and CD55-negative H69 cells (small cell lung carcinoma) (Fig. 2d). This evidence concerns the gene CD55 and non-small cell lung carcinoma.